Drug Companies Cited Over Lack of Stability Testing

The US FDA provides a comprehensive public record of the citations and warning letters [1] issued to Pharmaceutical Companies. This provides an excellent resource for those looking for guidance to improve quality and mitigate risk. In the 2019 Fiscal year 81 warning letters were issued, the most in recent history, continuing the upward trend of the previous years.
[Read More]

Please to read the entire article.

You must be logged in to post a comment Login